217 related articles for article (PubMed ID: 7617825)
1. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.
Dawson GR; Crawford SP; Collinson N; Iversen SD; Tricklebank MD
Psychopharmacology (Berl); 1995 Apr; 118(3):316-23. PubMed ID: 7617825
[TBL] [Abstract][Full Text] [Related]
2. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
Collinson N; Dawson GR
Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
[TBL] [Abstract][Full Text] [Related]
3. Effects of ethanol, chlordiazepoxide, and MK-801 on performance in the elevated-plus maze and on locomotor activity.
Criswell HE; Knapp DJ; Overstreet DH; Breese GR
Alcohol Clin Exp Res; 1994 Jun; 18(3):596-601. PubMed ID: 7943661
[TBL] [Abstract][Full Text] [Related]
4. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.
Dawson GR; Crawford SP; Stanhope KJ; Iversen SD; Tricklebank MD
Psychopharmacology (Berl); 1994 Jan; 113(3-4):570-2. PubMed ID: 7862878
[TBL] [Abstract][Full Text] [Related]
5. The use of a plus-maze to measure anxiety in the mouse.
Lister RG
Psychopharmacology (Berl); 1987; 92(2):180-5. PubMed ID: 3110839
[TBL] [Abstract][Full Text] [Related]
6. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
7. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety.
Weiss SM; Wadsworth G; Fletcher A; Dourish CT
Neurosci Biobehav Rev; 1998; 23(2):265-71. PubMed ID: 9884119
[TBL] [Abstract][Full Text] [Related]
8. The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination.
Garcia AM; Cardenas FP; Morato S
Behav Brain Res; 2011 Feb; 217(1):171-7. PubMed ID: 20933019
[TBL] [Abstract][Full Text] [Related]
9. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.
Pellow S; Chopin P; File SE; Briley M
J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480
[TBL] [Abstract][Full Text] [Related]
10. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
12. The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.
Griebel G; Sanger DJ; Perrault G
Psychopharmacology (Berl); 1996 Apr; 124(3):245-54. PubMed ID: 8740046
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat.
Gower AJ; Falter U; Lamberty Y
Eur J Pharmacol; 2003 Nov; 481(1):67-74. PubMed ID: 14637176
[TBL] [Abstract][Full Text] [Related]
14. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
[TBL] [Abstract][Full Text] [Related]
15. The effects of buspirone on the behaviour of control and stressed mice.
Pokk P; Zharkovsky A
J Physiol Pharmacol; 1998 Mar; 49(1):175-85. PubMed ID: 9594420
[TBL] [Abstract][Full Text] [Related]
16. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Wada T; Fukuda N
Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
[TBL] [Abstract][Full Text] [Related]
17. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation.
Pereira JK; Vieira RJ; Konishi CT; Ribeiro RA; Frussa-Filho R
Life Sci; 1999; 65(10):PL101-7. PubMed ID: 10499876
[TBL] [Abstract][Full Text] [Related]
18. Mu-opioid receptor knockout mice are more sensitive to chlordiazepoxide-induced anxiolytic behavior.
Wang KC; Lee YJ; Fan LW; Yang PP; Tao PL; Ho IK; Tien LT
Brain Res Bull; 2013 Jan; 90():137-41. PubMed ID: 23142328
[TBL] [Abstract][Full Text] [Related]
19. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the rat exploratory behavior in the elevated plus-maze with Markov chains.
Tejada J; Bosco GG; Morato S; Roque AC
J Neurosci Methods; 2010 Nov; 193(2):288-95. PubMed ID: 20869398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
